Brandi Roberts insider trades
Open-market stock purchases and sales by Brandi Roberts, Chief Financial Officer at Definium Therapeutics, Inc, from SEC Form 4 filings since Jun 15, 2011.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -38%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 25, 2026 | DFTX Definium Therapeutics, Inc | Sold | $123K |
| Sep 14, 2026 | DFTX Definium Therapeutics, Inc | Bought (not open market) | — |
| Aug 12, 2026 | DFTX Definium Therapeutics, Inc | Bought (not open market) | — |
| Jun 25, 2026 | DFTX Definium Therapeutics, Inc | Sold | $136K |
| Jun 22, 2026 | DFTX Definium Therapeutics, Inc | Bought (not open market) | — |
| Feb 3, 2026 | DFTX Definium Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- DFTX Definium Therapeutics, Inc: 2 sales, last Sep 25, 2026
- MNMD Mind Medicine (MindMed) Inc: other filings, last Jun 2, 2025
- LBPH Longboard Pharmaceuticals, Inc: other filings, last Dec 2, 2024
- TFFP TFF Pharmaceuticals, Inc: 1 buy, last Jul 3, 2024
- LCTX Lineage Cell Therapeutics, Inc: 1 buy, last Mar 17, 2020
- BTX Biotime Inc: other filings, last Jun 30, 2019
- RVA.AX REVA Medical, Inc: 1 buy, last Jun 29, 2018
- RVA:AX REVA Medical, Inc: other filings, last Sep 18, 2017
- MSTX Mast Therapeutics, Inc: 2 buys, last Jan 20, 2017
- ANX Adventrx Pharmaceuticals Inc: other filings, last Jan 2, 2013